Closing Bell: Briacell Therapeutics Corp down on Friday (BCT)

In today's trading, Briacell Therapeutics Corp shares opened at $1.04 and closed at $1.05. prices ranged from a low of $1.03 to a high of $1.05.

Share prices eased -2.78% from the previous day's close of $1.08.

Today across North America, the TSX Composite closed -0.15% at 22779.57, the S&P 500 closed 1.11% at 5459.10, the Dow Jones Industrial Average closed 1.64% at 40589.34 and the Nasdaq Composite closed 1.03% at 17357.88.

Briacell Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker BCT.

A total of 1,605 shares was traded during the session, with total trades of 7. On average, Briacell Therapeutics Corp has traded 35,019 shares over the last 5-days and 10,175 year-to-date.

Trading across the entire TSX saw 1,903 price advancers against 3,356 declines and 91 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.84 (July 24,2024). Moreover, the shares have shrunken -86.88% in the last year, while they have plummeted -86.54% year-to-date.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $19.20 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Briacell Therapeutics Corp has an average recommendation of "Strong Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..